Transforming growth factor-β administration modifies cyclosporine A-induced bone loss
Authors:
- I.R DissanayakeIDI.R Dissanayake
- A.R BowmanABA.R Bowman
- S PunSPS Pun
- Y MaYMY Ma
- W.S.S JeeWJW.S.S Jee
- H.P BryerHBH.P Bryer
- S EpsteinSES Epstein
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Skeletal Effects of Low-Dose Cyclosporin A in Aged Male Rats: Lack of Relationship to Serum Testosterone LevelsJournal of Bone and Mineral Research, 1998
- The Role of Testosterone in Cyclosporine-Induced OsteopeniaJournal of Bone and Mineral Research, 1997
- T lymphocytes play a critical role in the development of cyclosporin A- induced osteopeniaEndocrinology, 1996
- Post-transplantation bone disease: The role of immunosuppressive agents and the skeletonJournal of Bone and Mineral Research, 1996
- Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.Journal of Cell Biology, 1996
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVOTransplantation, 1994
- 1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone lossCalcified Tissue International, 1990
- Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin aArthritis & Rheumatism, 1990
- BONE HISTOLOGY IN RENAL TRANSPLANT PATIENTS RECEIVING CYCLOSPORINThe Lancet, 1988